Share tips: No ordinary defence stock

Despite an impressive order book, this US defence stock has largely been discarded by investors, says Paul Hill.

Exelis (NYSE: XLS), rated BUY by EVA Dimensions

Exelis is in the doghouse. The mid-sized defence business was spun out of ITT last October. Since then, it has been largely discarded by investors, fearful of the US government's military belt-tightening. Yet Exelis is no ordinary defence stock. It specialises in advanced electronics and communications, used for operations such as cyber warfare and battlefield support.

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free
https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up

Paul gained a degree in electrical engineering and went on to qualify as a chartered management accountant. He has extensive corporate finance and investment experience and is a member of the Securities Institute.

Over the past 16 years Paul has held top-level financial management and M&A roles for blue-chip companies such as O2, GKN and Unilever. He is now director of his own capital investment and consultancy firm, PMH Capital Limited.

Paul is an expert at analysing companies in new, fast-growing markets, and is an extremely shrewd stock-picker.